- 专利标题： Radioactive labeling method for neuropeptide Y derivative compound and medicine for multi-type breast cancer therapy thereof
-
申请号： US16215647申请日： 2018-12-11
-
公开(公告)号： US20200237938A1公开(公告)日： 2020-07-30
- 发明人: Ming-Hsin Li , Su-Jung Chen , Ming-Wei Chen , Yuan-Ruei Huang , Shih-Ying Lee , Chun-Fang Feng , Sheng-Nan Lo , Chih-Hsien Chang
- 申请人： Ming-Hsin Li , Su-Jung Chen , Ming-Wei Chen , Yuan-Ruei Huang , Shih-Ying Lee , Chun-Fang Feng , Sheng-Nan Lo , Chih-Hsien Chang
- 主分类号： A61K51/08
- IPC分类号： A61K51/08 ; A61K51/04 ; A61K51/06
摘要：
The present invention provides a radioactive labeling method for neuropeptide Y (NPY) compound and a mammalian diagnostic radioactive targeting medicine with NPY peptide being modified at position 27th to 36th, and after binding with the chelating agent and labeling the radiation nucleus 66Ga, 67Ga, 68Ga, 177Lu or 111In to provide a radioactive targeting medicine for multi-type breast cancer diagnosis and treatment.
公开/授权文献
信息查询
